Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes.

Conclusions. Dexamethasone implant administered PRN improved VA and decreased CRT in CME, with possible long-term clinically relevant benefits for treating CME from various etiologies. Vitrectomized eyes needed more implants compared with nonvitrectomized eyes.
PMID: 27721989 [PubMed - in process]

Source: Journal of Ophthalmology - October 13, 2016 Category: Opthalmology Tags: J Ophthalmol Source Type: research